1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Schumann, F.H. Varadan, R. Tayakuniyil, P.P. Hall, J.B. Camarero, J.A. Fushman, D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Changing protein backbone topology: Structural and dynamic consequences of the backbone cyclization in SH3 domain UK J.Mol.Biol. JMOBAK 0070 0022-2836 308 1045 1062 10.1006/jmbi.2001.4631 Rescuing a destabilized protein fold through backbone cyclization 2001 10.2210/pdb1m3b/pdb pdb_00001m3b 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 6831.592 Proto-oncogene C-crk N-TERMINAL SH3 DOMAIN (residues 134-191) R191G, E135G, A134C 1 man polymer P38, Adapter molecule crk no no CGYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYG CGYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n house mouse Mus Escherichia sample CRK 10090 Mus musculus 562 Escherichia coli PLASMID PGEX-6P-1 database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-08-05 1 1 2008-04-28 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details Solution structure of N-terminal SH3 domain from oncogene protein c-Crk Solution structure of a circular form of the truncated N-terminal SH3 domain from oncogene protein c-Crk. Solution structure of a circular form of the N-terminal SH3 domain from oncogene protein c-Crk RCSB Y RCSB 2002-06-27 REL REL This structure was determined using standard 2D homonuclear techniques combined with 2D 1H-15N HSQC data. structures with the lowest target function 200 20 2D TOCSY 2D NOESY DQF-COSY 2D HSQC 2D TOCSY 100 mM NaCl 7.2 ambient 307 K The structures are based on 1151 restraints, 1054 are NOE-derived distance contraints, 25 dihedral angle constraints, and 72 distance restraints from hydrogen bonds. Structures were calculated using program DYANA. No further refinement was performed. Simulated annealing combined with torsion angle dynamics 1 lowest target function 1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 90% H2O/10% D2O 1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 90% H2O/10% D2O Bruker collection XwinNMR 2.6,3.0 Bartels, Xia, Wuethrich data analysis XEASY 1.3.1.3 Guentert structure solution DYANA 1.5 Guentert, Wuethrich refinement DYANA 500 Bruker DMX 600 Bruker DMX 600 Bruker DRX CYS 134 n 1 CYS 134 A GLY 135 n 2 GLY 135 A TYR 136 n 3 TYR 136 A VAL 137 n 4 VAL 137 A ARG 138 n 5 ARG 138 A ALA 139 n 6 ALA 139 A LEU 140 n 7 LEU 140 A PHE 141 n 8 PHE 141 A ASP 142 n 9 ASP 142 A PHE 143 n 10 PHE 143 A ASN 144 n 11 ASN 144 A GLY 145 n 12 GLY 145 A ASN 146 n 13 ASN 146 A ASP 147 n 14 ASP 147 A GLU 148 n 15 GLU 148 A GLU 149 n 16 GLU 149 A ASP 150 n 17 ASP 150 A LEU 151 n 18 LEU 151 A PRO 152 n 19 PRO 152 A PHE 153 n 20 PHE 153 A LYS 154 n 21 LYS 154 A LYS 155 n 22 LYS 155 A GLY 156 n 23 GLY 156 A ASP 157 n 24 ASP 157 A ILE 158 n 25 ILE 158 A LEU 159 n 26 LEU 159 A ARG 160 n 27 ARG 160 A ILE 161 n 28 ILE 161 A ARG 162 n 29 ARG 162 A ASP 163 n 30 ASP 163 A LYS 164 n 31 LYS 164 A PRO 165 n 32 PRO 165 A GLU 166 n 33 GLU 166 A GLU 167 n 34 GLU 167 A GLN 168 n 35 GLN 168 A TRP 169 n 36 TRP 169 A TRP 170 n 37 TRP 170 A ASN 171 n 38 ASN 171 A ALA 172 n 39 ALA 172 A GLU 173 n 40 GLU 173 A ASP 174 n 41 ASP 174 A SER 175 n 42 SER 175 A GLU 176 n 43 GLU 176 A GLY 177 n 44 GLY 177 A LYS 178 n 45 LYS 178 A ARG 179 n 46 ARG 179 A GLY 180 n 47 GLY 180 A MET 181 n 48 MET 181 A ILE 182 n 49 ILE 182 A PRO 183 n 50 PRO 183 A VAL 184 n 51 VAL 184 A PRO 185 n 52 PRO 185 A TYR 186 n 53 TYR 186 A VAL 187 n 54 VAL 187 A GLU 188 n 55 GLU 188 A LYS 189 n 56 LYS 189 A TYR 190 n 57 TYR 190 A GLY 191 n 58 GLY 191 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O ILE 182 A O ILE 49 A N TRP 170 A N TRP 37 A O ASN 171 A O ASN 38 A N ASP 163 A N ASP 30 A O LEU 159 A O LEU 26 A N VAL 137 A N VAL 4 A N TYR 136 A N TYR 3 A O GLY 191 A O GLY 58 3 A A O HE1 GLU TRP 166 170 1.50 9 A A O H ALA GLY 139 156 1.57 15 A A O HE1 GLU TRP 166 170 1.60 17 A A O H ASP ASP 147 150 1.59 19 A A O H ASP GLU 147 149 1.54 1 A ASN 146 -159.47 60.66 1 A GLU 148 -86.63 39.16 1 A GLU 149 -144.49 -39.73 1 A GLN 168 -155.40 -49.93 1 A ASP 174 -57.41 176.69 2 A ASN 146 176.38 48.20 2 A GLU 148 -81.64 45.87 2 A GLU 149 -160.41 -37.63 2 A GLN 168 -171.67 -60.89 2 A ASP 174 -55.02 171.07 2 A SER 175 -77.94 29.93 3 A PHE 141 -170.62 135.14 3 A ASN 146 -173.70 -58.64 3 A ASP 147 166.09 123.91 3 A GLN 168 170.15 -66.52 3 A SER 175 -80.59 31.61 4 A PHE 141 -165.20 118.45 4 A ASN 146 178.03 -36.36 4 A GLU 148 -87.06 31.71 4 A LYS 155 -47.16 106.77 4 A GLN 168 79.43 -51.95 4 A TYR 190 -111.18 75.34 5 A TYR 136 -144.45 -144.83 5 A LEU 140 -99.51 40.11 5 A ASN 146 -179.05 74.55 5 A GLU 148 -86.14 43.18 5 A GLU 149 -154.83 -41.00 5 A GLU 166 -51.61 176.67 5 A GLN 168 -175.84 -56.71 5 A ASP 174 -54.39 173.43 6 A LEU 140 -106.12 42.17 6 A ASN 146 -174.34 -45.24 6 A GLU 148 -86.02 39.34 6 A ARG 162 -101.24 -64.87 6 A LYS 164 84.78 100.14 6 A GLU 166 30.99 -145.73 6 A GLU 167 -165.74 44.96 6 A GLN 168 -175.23 -60.61 6 A ASP 174 -57.33 172.55 6 A TYR 186 -84.99 40.58 7 A LEU 140 -107.77 47.45 7 A PHE 141 178.12 134.40 7 A ASN 146 178.57 43.55 7 A ASP 147 54.72 174.22 7 A GLU 149 178.60 -34.95 7 A ASP 150 167.81 124.83 7 A GLN 168 76.27 -52.45 7 A ASP 174 -56.70 173.78 7 A TYR 186 -91.55 33.74 8 A LEU 140 -97.86 41.63 8 A ASN 146 177.34 38.42 8 A ASP 147 74.70 42.90 8 A GLU 148 -98.36 46.91 8 A LYS 155 -52.35 109.22 8 A GLU 166 -78.74 -168.34 8 A GLN 168 162.04 -60.26 8 A ASP 174 -59.04 175.95 8 A TYR 186 -88.90 44.38 9 A LEU 140 -104.44 43.72 9 A ASN 146 169.69 -54.84 9 A GLU 148 -85.97 36.55 9 A GLU 166 -61.80 -175.83 9 A GLN 168 154.83 -74.49 9 A SER 175 -81.74 31.41 10 A ASN 146 -170.00 -42.82 10 A GLU 166 -60.83 -178.10 10 A GLN 168 -153.62 -45.01 10 A ASP 174 -52.14 179.59 10 A TYR 186 -90.95 30.65 11 A PHE 141 -174.48 125.08 11 A ASN 146 -177.94 -61.77 11 A ASP 147 -176.97 124.04 11 A LYS 155 -56.16 102.34 11 A GLN 168 -148.97 -47.58 11 A ASP 174 -55.37 178.22 12 A LEU 140 -108.54 45.37 12 A PHE 141 -171.73 125.72 12 A ASN 146 -178.53 -42.18 12 A GLU 148 -85.67 35.37 12 A GLU 167 -113.80 57.55 12 A GLN 168 -170.73 -67.84 13 A LEU 140 -94.27 41.19 13 A PHE 141 -178.90 130.42 13 A ASN 144 176.01 141.77 13 A ASN 146 -171.67 -46.08 13 A GLU 148 -83.93 38.02 13 A GLU 149 -160.52 39.85 13 A PHE 153 -109.11 -163.53 13 A LYS 154 -177.44 147.37 13 A LYS 164 -150.44 58.44 13 A GLN 168 85.49 -56.97 13 A SER 175 -77.19 28.79 14 A TYR 136 -109.25 -151.87 14 A PHE 141 -173.96 131.43 14 A ASN 146 177.72 47.99 14 A GLU 148 -80.50 47.72 14 A GLU 149 -165.96 -39.02 14 A LYS 164 -156.58 63.78 14 A GLN 168 171.73 -67.83 14 A ASP 174 -55.75 174.88 15 A LEU 140 -103.26 43.67 15 A PHE 141 -174.52 121.36 15 A ASN 144 -103.45 -79.94 15 A ASN 146 164.47 88.68 15 A ASP 147 -40.82 160.93 15 A GLU 148 -76.88 44.58 15 A GLU 149 -140.70 -36.82 15 A PRO 165 -74.95 -76.35 15 A GLU 166 -51.92 179.06 15 A GLN 168 -155.03 -43.35 15 A SER 175 -75.79 30.19 16 A LEU 140 -109.37 48.08 16 A ASN 146 -178.32 37.22 16 A ASP 147 54.44 170.61 16 A GLU 148 69.94 -60.94 16 A ASP 150 179.80 149.35 16 A LYS 164 -155.48 57.51 16 A PRO 165 -75.01 40.16 16 A GLN 168 176.14 -62.88 16 A ASP 174 -57.29 172.72 16 A SER 175 -79.54 27.60 17 A LEU 140 -108.31 46.52 17 A PHE 141 -171.87 119.88 17 A ASN 144 -70.08 -71.12 17 A ASN 146 172.57 39.16 17 A GLU 148 -38.35 -39.15 17 A ARG 162 -122.63 -52.68 17 A GLN 168 78.65 -51.90 17 A ASP 174 -53.35 171.27 17 A SER 175 -77.55 29.89 18 A ASN 144 -174.31 77.48 18 A ASN 146 173.90 -53.97 18 A ASP 147 -170.12 119.26 18 A GLN 168 -172.81 -65.72 18 A SER 175 -83.34 30.53 18 A TYR 190 -123.13 -67.10 19 A LEU 140 -119.77 50.30 19 A PHE 141 -178.23 133.17 19 A ASN 144 -103.43 -74.78 19 A ASN 146 160.76 51.59 19 A GLU 148 66.69 -58.23 19 A LEU 151 -39.61 110.39 19 A ARG 162 -120.54 -59.30 19 A GLN 168 81.39 -54.54 19 A ASP 174 -56.14 171.36 19 A TYR 190 -157.90 82.54 20 A ASN 146 174.20 68.11 20 A GLU 148 -79.78 42.26 20 A GLU 149 -142.99 -41.84 20 A GLN 168 78.51 -51.91 20 A ASP 174 -49.63 170.74 Solution structure of a circular form of the N-terminal SH3 domain (A134C, E135G, R191G mutant) from oncogene protein c-Crk. 1 N N covale 1.494 both A CYS 134 A N CYS 1 1_555 A GLY 191 A C GLY 58 1_555 PROTEIN BINDING SH3, SH3 DOMAIN, CIRCULAR PROTEIN, CYCLIZED PROTEIN, ADAPTOR PROTEIN, PROTEIN BINDING CRK_MOUSE UNP 1 134 Q64010 AEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYR 134 191 1M3B 134 191 Q64010 A 1 1 58 1 ALA engineered mutation CYS 134 1M3B A Q64010 UNP 134 1 1 GLU engineered mutation GLY 135 1M3B A Q64010 UNP 135 2 1 ARG engineered mutation GLY 191 1M3B A Q64010 UNP 191 58 5 anti-parallel anti-parallel anti-parallel anti-parallel A ARG 179 A ARG 46 A PRO 183 A PRO 50 A TRP 169 A TRP 36 A ASP 174 A ASP 41 A LYS 155 A LYS 22 A ASP 163 A ASP 30 A TYR 136 A TYR 3 A LEU 140 A LEU 7 A VAL 187 A VAL 54 A GLY 191 A GLY 58